Reaction

Fanconi Syndrome Acquired reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,728 reports · 46 co-occurring drugs

As of the last recalculation, Fanconi Syndrome Acquired appears in 1,728 FAERS reports alongside 46 co-occurring drug terms. The strongest observed disproportionality signal is TENOFOVIR DISOPROXIL FUMARATE (PRR 313.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Tenofovir Disoproxil Fumarate575313.5319.1
Tenofovir Disoproxil Fumarate Tablets150229.1233.1
Emtricitabine And Tenofovir Disoproxil Fumarate369123.6124.6
Lamivudine260119.1120.1
Lopinavir And Ritonavir121115.6116.6
Lamivudine Oral210113.7114.6
Atazanavir10088.989.5
Abacavir Sulfate6786.186.7
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate5981.782.2
Emtricitabine And Tenofovir Alafenamide7077.577.9
Entecavir7075.275.7
Ritonavir16072.673.0
Efavirenz5662.562.8
Dolutegravir Sodium4460.360.6
Ritonavir 100 Mg6655.355.5
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate7955.055.2
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide4454.054.3
Darunavir6553.854.0
Raltegravir6750.851.0
Zidovudine3835.035.1
Nevirapine1925.625.7
Ifosfamide4324.724.7
Deferasirox5123.823.9
Mesna Injection1116.116.2
Mesna1115.815.9
Zoledronic Acid5015.415.4
Calcitriol Capsules 0.25 Mcg2414.614.6
Calcitriol Capsules 0.5 Mcg2414.614.6
Calcitriol2414.414.5
Sodium Bicarbonate2513.113.1
Sodium Bicarbonate Injection,2513.113.1
Daspone1012.412.4
Dapsone Gel, 5%1012.412.4
Dronabinol812.012.0
Ampicillin811.711.7
Ampicillin Sodium811.711.7
Dapsone1011.311.4
Atovaquone710.510.5
Benzonatate128.88.8
Valproic Acid218.18.1
Abiraterone98.08.0
Clobazam168.08.0
Bicalutamide107.97.9
Loperamide Hcl87.57.5
Ledipasvir And Sofosbuvir106.36.3
Abiraterone Acetate113.23.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.